Trial Profile
A 12-week, Randomised, Double-blind, Placebo-controlled Trial to Evaluate the Efficacy and Safety of Prucalopride in Subjects With Chronic Non-cancer Pain Suffering From Opioid Induced Constipation.
Status:
Discontinued
Phase of Trial:
Phase III
Latest Information Update: 17 Oct 2021
Price :
$35
*
At a glance
- Drugs Prucalopride (Primary)
- Indications Constipation
- Focus Therapeutic Use
- Sponsors Shire
- 14 Oct 2021 This trial has been completed in France (Global end date: 13 Aug 2012).
- 01 Feb 2013 Status changed from active, no longer recruiting to discontinued as reported by ClinicalTrials.gov record.
- 11 Jun 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.